Understanding Lung Cancer Stages: I Through IV

Lung cancer staging, most commonly using a I-through-IV system for NSCLC, describes how far the cancer has spread from where it started, and is central to how clinical trials and treatment approaches are organized.

Staging generally considers three factors: the size and extent of the primary tumor, whether cancer has spread to nearby lymph nodes, and whether it has spread (metastasized) to distant parts of the body. Stage I generally describes cancer confined to the lung; Stage IV generally describes cancer that has spread to distant organs.

Small cell lung cancer is often described using a simpler two-category system instead — limited stage or extensive stage — reflecting how frequently SCLC has already spread by the time it is diagnosed.

Stage at diagnosis is one of the strongest known predictors of five-year survival statistics, which is a central reason early detection research, including screening and liquid biopsy technology, remains such an active research priority.